Safety and Antimalarial Therapeutic Index of Alkaloid-rich Extract of Schumach. & Thonn. in Mice

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Dec 11

PMID 38076132

Authors

Solomon U Okom

Evelyn T Ojugbeli

Joel Okpoghono

Innocent Onyesom

Affiliations

Soon will be listed here.

Abstract

Background: Malaria fever is known to cause around one million passings per annum. This life-threatening infection is predominant in most part of Africa. Malaria vaccinations are challenging in Nigeria, particularly in rural areas. Drugs derived from plants have been utilized customarily to treat malaria. In this manner, assurance of the harmfulness and antimalarial capacity of plant derived drugs can demonstrate to be the source of novel lead compound to control malaria. The aim of this study was to evaluate the safety and antimalarial therapeutic index of alkaloid-rich extract of in mice.

Methods: Thirty rats (n = 5/group) were used for the oral acute toxicity study and administered with varying doses (0, 100, 500, 1000, 2000 and 5000 mg/kg b.wt) of alkaloid-rich extract of The oral acute toxicity was carried out according to OECD guidelines.After 21 days of monitoring, serum liver function tests and liver histology were performed using documented methods. The antimalarial index was determined using median effective dose (ED) of thirty five mice divided into 7 groups (n = 5).

Results: showed that up to the highest dose (5000 mg/kg), there were no biochemical derangements in liver function. Physical signs of toxicity were also not observed. Antimalarial activity indices showed high potency with therapeutic index of 30.13.

Conclusion: Alkaloid-rich extract of is therefore, non-toxic with reputable antimalarial activity. The active alkaloid(s) deserve further study as source for possible development of new and more potent antimalarial agent.

Citing Articles

Natural polyphenols: A protective approach to reduce colorectal cancer.

Okpoghono J, Isoje E, Igbuku U, Ekayoda O, Omoike G, Adonor T Heliyon. 2024; 10(11):e32390.

PMID: 38961927 PMC: 11219337. DOI: 10.1016/j.heliyon.2024.e32390.

References

Osei S, Biney R, Obese E, Agbenyeku M, Attah I, Ameyaw E . Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice. Malar J. 2021; 20(1):113. PMC: 7908739. DOI: 10.1186/s12936-021-03658-6. View

Ogunmoyole T, Awodooju M, Idowu S, Daramola O . extract restored deranged biochemical parameters in rat model of hepatotoxicity and nephrotoxicity. Heliyon. 2020; 6(12):e05670. PMC: 7753912. DOI: 10.1016/j.heliyon.2020.e05670. View

Nayyar G, Breman J, Newton P, Herrington J . Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012; 12(6):488-96. DOI: 10.1016/S1473-3099(12)70064-6. View

Henry J, Carter A, Smith D . Infection age as a predictor of epidemiological metrics for malaria. Malar J. 2022; 21(1):117. PMC: 8991475. DOI: 10.1186/s12936-022-04134-5. View

Travassos M, Laufer M . Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations. Pediatr Res. 2009; 65(5 Pt 2):64R-70R. PMC: 2837525. DOI: 10.1203/PDR.0b013e3181a0977e. View

Dearden J, Hewitt M . Prediction of Human Lethal Doses and Concentrations of MEIC Chemicals from Rodent LD Values: An Attempt to Make Some Reparation. Altern Lab Anim. 2021; 49(1-2):10-21. DOI: 10.1177/0261192921994754. View

Patel J, Tripathi P, Sharma V, Chauhan N, Dixit V . Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol. 2011; 138(2):286-313. DOI: 10.1016/j.jep.2011.09.040. View

Knight D, Peters W . The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol. 1980; 74(4):393-404. View

Twaij H, Kery A . Some pharmacological, toxicological and phytochemical investigations on Centaurea phyllocephala. J Ethnopharmacol. 1983; 9(2-3):299-314. DOI: 10.1016/0378-8741(83)90037-5. View

10.

Fivelman Q, Adagu I, Warhurst D . Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2007; 51(6):2265-7. PMC: 1891407. DOI: 10.1128/AAC.01479-06. View

11.

Okokon J, Effiong I, Ettebong E . In vivo antimalarial activities of ethanolic crude extracts and fractions of leaf and root of Carpolobia lutea. Pak J Pharm Sci. 2010; 24(1):57-61. View

12.

Aliyu K, Mohammed Y, Abdullahi I, Umar A, Bashir F, Sani M . antiplasmodial activity of Phyllanthus amarus against and evaluation of its acute toxicity effect in mouse model. Trop Parasitol. 2021; 11(1):31-37. PMC: 8213120. DOI: 10.4103/tp.TP_78_20. View

13.

Diallo A, Eklu-Gadegbeku K, Amegbor K, Agbonon A, Aklikokou K, Creppy E . In vivo and in vitro toxicological evaluation of the hydroalcoholic leaf extract of Ageratum conyzoides L. (Asteraceae). J Ethnopharmacol. 2014; 155(2):1214-8. DOI: 10.1016/j.jep.2014.07.005. View

14.

Tamargo J, Le Heuzey J, Mabo P . Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015; 71(5):549-67. PMC: 4412688. DOI: 10.1007/s00228-015-1832-0. View

15.

Bosch J, Groszmann R, Shah V . Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015; 62(1 Suppl):S121-30. PMC: 4519833. DOI: 10.1016/j.jhep.2015.01.003. View

16.

Effiong F, Makata V, Elebesunu E, Bassey E, Salachi K, Sagide M . Prospects of malaria vaccination in Nigeria: Anticipated challenges and lessons from previous vaccination campaigns. Ann Med Surg (Lond). 2022; 81:104385. PMC: 9421322. DOI: 10.1016/j.amsu.2022.104385. View

17.

Nardos A, Makonnen E . In vivo antiplasmodial activity and toxicological assessment of hydroethanolic crude extract of Ajuga remota. Malar J. 2017; 16(1):25. PMC: 5237349. DOI: 10.1186/s12936-017-1677-3. View